SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Allogene Therapeutics Announces November Investor Events on Q3 Results and ALLO-329 Data

The company says its November investor events will highlight Q3 results and initial ALLO-329 autoimmune clinical data.

ALLO
SquawkNews Desk 1 updates Updated Oct 29, 2026, 12:31 PM UTC

Story updates

12:31:37 PM UTC
SquawkNews
Q3 2026 Financial Results and Business Update Conference Call and Webcast Scheduled for November 5,

Related stories

APR Co. Q3 Operating Profit Rises 69% to 160.6 Billion Won APR Co. reported Q3 operating profit of 160.6 billion won, up 69% from a year earlier. M impact | EQUITY | Oct 30, 2026, 01:10 AM UTC South Korea’s KOSPI Drops More Than 4%; Sell-Sidecar Triggered M impact | EQUITY | Oct 30, 2026, 01:09 AM UTC Way 2 VAT Reports Q3 FY26 Revenue of A$1.90 Million M impact | EQUITY | Oct 30, 2026, 01:09 AM UTC Vale Reports Third-Quarter Profit of $1.255 Billion, Down From $2.685 Billion Vale reported third-quarter earnings of $1.255 billion, or $0.29 per share, compared with $2.685 billion, or $0.63 per share, a year earlier. Revenue rose 1.7%. M impact | EQUITY | Oct 30, 2026, 01:08 AM UTC Monsanto gana por unanimidad primer juicio por glifosato El fallo del Supremo de EE. UU. precedió la victoria unánime de Monsanto en el juicio, según el titular. M impact | EQUITY | Oct 30, 2026, 01:08 AM UTC Bayer’s Monsanto Wins Missouri Glyphosate Case Unanimously M impact | EQUITY | Oct 30, 2026, 01:08 AM UTC